MedTrace Logo

Photon Therapy Versus Proton Therapy in Early Tonsil Cancer.

NCT03829033 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-09-01

No results posted yet for this study

Summary

In this trial, patients with early squamous cell carcinoma of the tonsil with clinical stage T1-2 (p16-positive or p16-negative) N0-1 (p16-positive)/N0-N2b (p16-negative) according to American Joint Committee on Cancer (AJCC) 8th edition, aimed for unimodal and ipsilateral treatment with radiotherapy with curative intent will be included. The patients will be randomized to in a 1:1 ratio to receive radiotherapy with either photons (conventional radiotherapy) versus radiotherapy with protons.

Conditions

  • Tonsil Cancer

Interventions

RADIATION

Radiotherapy

Radiotherapy with either photons or protons.

Sponsors & Collaborators

  • Lund University Hospital

    lead OTHER

Principal Investigators

  • Maria Gebre-Medhin, MD · Lund University Hospiyal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-22
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03829033 on ClinicalTrials.gov